Cancer Research
6 theme stocks in the Cancer Research theme, with a sum of listed market caps of $1.21T. On average they are down 0.02% today and up 46% over the past year.
Stocks6
Sum of listed market caps$1.21T
Average move today▼ 0.02%
Average 1-year return▲ 45.6%
Median P/E42.0
Avg dividend yield3.42%
Leading today
Biggest gainers in this group
Lagging today
Biggest decliners in this group
Breadth
How many members are up or down right now
2 advancing · 4 declining · 0 unchanged
All 6 stocks, largest first
| # | Stock | Price | Day | 1 year | Market cap | P/E (TTM) | Yield | 52-week range |
|---|---|---|---|---|---|---|---|---|
| 1 | MRK Merck & Co | $146.73 | ▼ 0.14% | ▲ 74.0% | $361.73B | 148.2 | 2.32% | |
| 2 | NVS Novartis AG | $162.55 | ▲ 0.38% | ▲ 32.5% | $307.00B | 31.0 | 2.92% | |
| 3 | GILD Gilead Sciences | $166.89 | ▼ 0.41% | ▲ 43.1% | $207.00B | – | 1.95% | |
| 4 | PFE Pfizer | $29.39 | ▼ 0.20% | ▲ 26.5% | $167.52B | 42.0 | 5.85% | |
| 5 | BMY Bristol-Myers Squibb | $62.14 | ▼ 1.57% | ▲ 37.6% | $127.02B | 13.8 | 4.06% | |
| 6 | BIIB Biogen | $248.35 | ▲ 1.81% | ▲ 59.7% | $36.71B | 107.5 | – |
"1 year" is the price change over the past 365 days. P/E is trailing. For reference only, not investment advice.